tirzepatide jama Combined and Ixekizumab Therapy Shows Dual Benefits in Psoriasis: People Who Stopped Taking the

Studies with greater sample sizes and longer periods of follow-up are further needed to support the effectiveness of semaglutide.

Clinical studies have shown little difference in weight loss between those using HCG and those using a placebo

J Drug Metab Toxicol 7: 2

According to the official website, Ozempic may cause thyroid tumors, including cancer

It remains investigational, with approval not expected before late 2027

Conclusion: A Strategic Reinvention for the GLP-1 Era Biocons recent quarter reflects a company in transitionstrengthening its balance sheet, expanding its biosimilars leadership, and aggressively moving into one of the fastest-growing therapeutic markets in the world